Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 12, 2001 - Issue 3
Submit an article Journal homepage
19
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Acute rhabdomyolysis during the treatment of scleromyxedema with interferon alfa

F Ozdag, A Akar, E Eroglu, H Erbil 1Department of Neurology and Department of Dermatology, GATA School of Medicine, Ankara, Turkey
Pages 167-169 | Published online: 12 Jul 2009

  • Dinneen AM, Dicken CH, Scleromyxedema. J Am Acad Dermatol(1995)33: 37-43.
  • Teschen JA, Chang JR, Scleromyxedema: treatment with interferon alfa. J Am Acad Dermatol(1999) 40: 303-7.
  • Duncan MR, Berman B, Persistence of a reduced collagenproducing phenotype in cultured scleroderma tibroblasts after short term exposure to interferons. J Clin Invest (1987) 79: 1318-24.
  • Reinhold U, Hartl C, Hering R, et al, Fatal rhabdomyolysis and multiple organ failure associated with interferon alfa in malign melanoma. lancet (1997) 349: 540-1 (letter).
  • Anderlini P, Buzaid AC, Legha SS, Acute rhabdomyolysis after concurrent administration of Interleukin-2, Interferon-alfa, and chemotherapy for metastatic melanoma. Cancer (1995) 76: 678-9.
  • Greenfield S, Harvey R, Thompson R, Rhabdomyolysis after treatment with interferon alfa. Br Med J (1994) 309: 512 (letter).
  • Helfrich Dj, Walker KR, Martinez AJ, Medsger TA, SeIeromyxedema myopathy: ease report and review of the literature. Arthritis Rheum (1988) 31: 1437-41.
  • Webster GF, Matsuoka LY, Burehmore D, The association of potentially lethal neurologic syndromes with seleromyxedema (papular mucinosis). J Am Acad Dermatol (1993) 28: 105-8.
  • Rothe MJ, Rivas R, Gould K, Kerdel FA, Scleromyxedema and severe myositis. Int J Dermatol(1989) 28: 657-60.
  • Rongioletti Rebora A, Paradoxical effect of Interferon alfa on lichen myxedematosus. J Acad Dermatol (2000) 43: 730 (letter).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.